Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study

Abstract

This multicentre study was aimed at comparing the trough effect of telmisartan and perindopril on diastolic blood pressure (DBP), using self blood pressure measurement (SBPM). A second objective was to compare the data obtained from SBPM with those provided by automatic office BP measurement. A total of 441 mild-to-moderate hypertensive patients were randomised to receive either telmisartan 40 mg or perindopril 4 mg for a period of 12 weeks. Patients whose clinic DBP remained higher than or equal to 90 mmHg at the end of the 6th week (W6) were given a double-dose regimen. Office BP and SBPM were performed at baseline (W0), at W6 and at week 12 (W12), both with the same automatic device. A greater diminution of trough DBP was obtained with telmisartan (−6.6±6.7 mmHg) than with perindopril (−5.1±7.0 mmHg; P=0.018). Regarding clinic BP, the same results were observed. Doubling dose was significantly less frequent with telmisartan (41%; n=85) than with perindopril (55%; n=115, P=0.005). Mean values of SBPM were lower than office BP values, with a difference of a greater importance at W0 than at W12: 6.6 vs 4.7 mmHg for systolic blood pressure (P<0.005) and 3.2 vs 1.4 mmHg for DBP (P<0.0001). At W12, isolated office hypertension was found in 9% of the patients (n=37), while there were 14% of the patients (n=55) with isolated home hypertension. In conclusion, the trough effect on DBP was statistically higher with telmisartan than with perindopril. SBPM values were lower than office BP values, with greater differences before than after treatment. About a quarter of the patients were found to be controlled with a method but not with the other one.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Abe H et al. Relation of office and home blood pressure to left ventricular hypertrophy and performance in patients with hypertension High Blood Press 1992 1: 279–285

    Google Scholar 

  2. Ohkubo T et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan J Hypertens 1998 16: 971–975

    Article  CAS  Google Scholar 

  3. Nesbitt SD et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh study Am J Hypertens 1997 10: 1270–1280

    Article  CAS  PubMed  Google Scholar 

  4. James JD, Pickering TG, Yees LS . Reproducibility of average ambulatory, home and clinic pressures Hypertension 1998 11: 545–549

    Article  Google Scholar 

  5. Sakuma M et al. Reproducibility of home blood pressure measurements over a one-year period Am J Hypertens 1997 10: 798–803

    Article  CAS  PubMed  Google Scholar 

  6. Carnahan JE, Nugent CA . The effects of self-monitoring by patients on the control of hypertension Am J Med Sci 1975 269: 69–73

    Article  CAS  PubMed  Google Scholar 

  7. Zarnke K, Feagan B, Mahon J, Feldman RD . A randomized study comparing a patient-directed hyper-tension management strategy with usual office-based care Am J Hypertens 1997 10: 58–67

    Article  CAS  PubMed  Google Scholar 

  8. Edmonds D et al. Does self-measurement of blood pressure improve patient compliance in hypertension? J Hypertens 1985 3 (Suppl) S31–S34

    Article  CAS  Google Scholar 

  9. Pickering T . Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel Am J Hypertens 1996 9: 1–11

    Article  CAS  PubMed  Google Scholar 

  10. Soghikan K et al. Home blood pressure monitoring: effect on use of medical services and medical care costs Med Care 1992 30: 855–865

    Article  Google Scholar 

  11. O'Brien E, Mee F, Atkins N, Thomas M . Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175 Blood Press Monit 1996 1: 55–61

    CAS  PubMed  Google Scholar 

  12. Asmar R, Zanchetti A . Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference. Groupe Evaluation & Measure of the French Society of Hypertension J Hypertens 2000 18: 493–508

    Article  CAS  PubMed  Google Scholar 

  13. Bland JM, Altman DG . Statistical methods for assessing agreement between two methods of measurement Lancet 1986 I: 307–310

    Article  Google Scholar 

  14. Neutel JM et al. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension Am J Ther 1999 6: 161–166

    Article  CAS  PubMed  Google Scholar 

  15. Smith DH, Matzek KM, Kempthorne-Rawson J . Dose response and safety of telmisartan in patients with mild to moderate hypertension J Clin Pharmacol 2000 40: 1380–1390

    Article  CAS  PubMed  Google Scholar 

  16. Smith DH, Neutel JM, Morgenstern P . Once daily telmisartan compared with enalapril in the treatment of hypertension Adv Ther 1998 15: 229–240

    CAS  Google Scholar 

  17. Neutel JM, Smith DH, Reilly PA . The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension Int J Clin Pract 1999 53: 175–178

    CAS  PubMed  Google Scholar 

  18. Karlberg BE, Lins LE, Hermansson K . Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group J Hypertens 1999 17: 293–302

    Article  CAS  PubMed  Google Scholar 

  19. Mallion JM, Siché JP, Lacoucière Y the Telmisartan Blood Pressure Monitoring Group. ABPM comparison of the antihypertensive profiles of the selective angio-tensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension J Hum Hypertens 1999 13: 657–664

    Article  CAS  PubMed  Google Scholar 

  20. Lacourcière Y et al. A comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine Blood Press Monit 1998 3: 295–302

    PubMed  Google Scholar 

  21. Lacourcière Y et al. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy J Hum Hypertens 2001 15: 763–770

    Article  PubMed  Google Scholar 

  22. Dickerson JE et al. Optimisation of antihypertensive treatment by crossover rotation of four major classes Lancet 1999 353: 2008–2013

    Article  CAS  PubMed  Google Scholar 

  23. Ragot S, Genes N, Vaur L, Herpin D . Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response Am J Hypertens 2000 13: 632–639

    Article  CAS  Google Scholar 

  24. Brook RD . Home blood pressure: accuracy is independent of monitoring schedules An J Hypertens 2000 13: 625–631

    Article  CAS  Google Scholar 

  25. Kjeldsen SE et al. Hypertension optimal treatment (HOT) study. Home blood pressure in treated hypertensive subjects Hypertension 1998 31: 1014–1020

    Article  CAS  PubMed  Google Scholar 

  26. Parati G, Omboni S, Mancia G . Difference between office and ambulatory blood pressure and response to antihypertensive treatment J Hypertens 1996 14: 791–797

    Article  CAS  PubMed  Google Scholar 

  27. Ima Y et al. Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial J Hypertens 2001 19: 179–185

    Article  Google Scholar 

  28. Bobrie G et al. Is isolated home hypertension as opposed to isolated office hypertension a sign of greater cardiovascular risk? Arch Intern Med 2001 161: 2205–2211

    Article  CAS  PubMed  Google Scholar 

  29. Karlberg BE, Lins LE, Hermansson K for the TEES Study Group. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension J Hypertens 1999 17: 293–302

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Ragot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ragot, S., Ezzaher, A., Meunier, A. et al. Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study. J Hum Hypertens 16, 865–873 (2002). https://doi.org/10.1038/sj.jhh.1001494

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001494

Keywords

This article is cited by

Search

Quick links